Bikang Pharmaceuticals

YanAn Bicon Pharmaceutical Listed Company (commonly known as Bikang Pharmaceuticals) is a China-based pharmaceutical and chemical manufacturing company. The company operates across three primary segments: Pharmaceuticals, New Materials, and Pharmaceutical Intermediates. In the pharmaceutical sector, it focuses on the research, development, production, and distribution of modern Chinese medicines, generic drugs, and OTC products targeting cardiovascular, digestive, respiratory, nervous system, and ophthalmic diseases. Its chemical divisions produce key pharmaceutical intermediates (such as 7-ADCA and benzaldehyde) and new energy materials like lithium hexafluorophosphate. Although delisted from the Shenzhen Stock Exchange in July 2023, the company continues its operations and is traded on the National Equities Exchange and Quotations (NEEQ).